Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

347 ARTíCULOS , VIENDO DEL 91 AL 105

PUBMED

An image-based model of brain volume biomarker changes in Huntington's disease.

Wijeratne PA, Young AL, Oxtoby NP, Marinescu RV, Firth NC, Johnson EB, Mohan A, Sampaio C, Scahill RI, Tabrizi SJ, Alexander DC.

Ann Clin Transl Neurol. 2018 Apr 2;5(5):570-582. doi: 10.1002/acn3.558. eCollection 2018 May.

0

0

0

PUBMED

SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease.

Baldo B, Gabery S, Soylu-Kucharz R, Cheong RY, Henningsen JB, Englund E, McLean C, Kirik D, Halliday G, Petersén Å.

Neuropathol Appl Neurobiol. 2018 Jul 18. doi: 10.1111/nan.12514. [Epub ahead of print]

0

0

0

PUBMED

Perinatal insults and neurodevelopmental disorders may impact Huntington's disease age of diagnosis.

Barkhuizen M, Rodrigues FB, Anderson DG, Winkens B; REGISTRY Investigators of the European Huntington's Disease Network., Wild EJ, Kramer BW, Gavilanes AWD.

Parkinsonism Relat Disord. 2018 May 18. pii: S1353-8020(18)30246-3. doi: 10.1016/j.parkreldis.2018.05.016. [Epub ahead of print]

0

0

0

PUBMED

Histone methylation in Huntington's disease: are bivalent promoters the critical targets?

Zsindely N, Bodai L.

Neural Regen Res. 2018 Jul;13(7):1191-1192. doi: 10.4103/1673-5374.235029. No abstract available.

0

0

0

PUBMED

Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.

Barry J, Akopian G, Cepeda C, Levine MS.

J Neurosci. 2018 May 16;38(20):4678-4694. doi: 10.1523/JNEUROSCI.0434-18.2018. Epub 2018 Apr 24.

0

0

0

PUBMED

In vivo neutralization of the protagonist role of macrophages during the chronic inflammatory stage of Huntington's disease.

Pido-Lopez J, Andre R, Benjamin AC, Ali N, Farag S, Tabrizi SJ, Bates GP.

Sci Rep. 2018 Jul 30;8(1):11447. doi: 10.1038/s41598-018-29792-x.

0

0

0

PUBMED

Mitochondrial Dysfunction in Huntington's Disease.

Carmo C, Naia L, Lopes C, Rego AC.

Adv Exp Med Biol. 2018;1049:59-83. doi: 10.1007/978-3-319-71779-1_3.

0

0

0

PUBMED

Salivary levels of total huntingtin are elevated in Huntington's disease patients.

Corey-Bloom J, Haque AS, Park S, Nathan AS, Baker RW, Thomas EA.

Sci Rep. 2018 May 9;8(1):7371. doi: 10.1038/s41598-018-25095-3.

0

0

0

PUBMED

MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study.

Reed ER, Latourelle JC, Bockholt JH, Bregu J, Smock J, Paulsen JS, Myers RH; PREDICT-HD CSF ancillary study investigators..

Neurology. 2018 Jan 23;90(4):e264-e272. doi: 10.1212/WNL.0000000000004844. Epub 2017 Dec 27.

0

0

0

PUBMED

Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington's disease.

Aron R, Pellegrini P, Green EW, Maddison DC, Opoku-Nsiah K, Wong JS, Daub AC, Giorgini F, Finkbeiner S.

Nat Commun. 2018 Sep 28;9(1):3191. doi: 10.1038/s41467-018-05653-z.

0

0

0

PUBMED

Systematic genetic interaction studies identify histone demethylase Utx as potential target for ameliorating Huntington's disease.

Song W, Zsindely N, Faragó A, Marsh JL, Bodai L.

Hum Mol Genet. 2018 Feb 15;27(4):759. doi: 10.1093/hmg/ddy020. No abstract available.

0

0

0

PUBMED

The visual cortex and visual cognition in Huntington's disease: an overview of current literature.

Coppen EM, van der Grond J, Hart EP, Lakke EAJF, Roos RAC.

Behav Brain Res. 2018 May 21. pii: S0166-4328(18)30165-7. doi: 10.1016/j.bbr.2018.05.019. [Epub ahead of print] Review.

0

0

0

PUBMED

Huntington modeling improves with age.

Mattis VB, Svendsen CN.

Nat Neurosci. 2018 Feb 23. doi: 10.1038/s41593-018-0086-4. [Epub ahead of print] No abstract available.

0

0

0

PUBMED

Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington's disease.

Di Pardo A, Castaldo S, Amico E, Pepe G, Marracino F, Capocci L, Giovannelli A, Madonna M, van Bergeijk J, Buttari F, van der Kam E, Maglione V.

Hum Mol Genet. 2018 Jul 15;27(14):2490-2501. doi: 10.1093/hmg/ddy153.

0

0

0

PUBMED

Alteration of GABAergic neurotransmission in Huntington's disease.

Garret M, Du Z, Chazalon M, Cho YH, Baufreton J.

CNS Neurosci Ther. 2018 Feb 21. doi: 10.1111/cns.12826. [Epub ahead of print] Review.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy